University of Tasmania, Australia

The Tasmanian MCI study is a longitudinal study that commenced in 2006. In 2012 the results of the study led to the publication of a paper describing a set of diagnostic markers that identified those adults with MCI who would develop Alzheimer’s Dementia within 2 years with 86% accuracy. In 2011 we recruited a second sample of adults with various subtypes of MCI and undertook a review of the diagnostic criteria published in 2012. During 2013 we expect finalise the diagnostic markers for later development of dementia in those adults with MCI and to increase the sensitivity and specificity of the diagnostic profile. Being able to accurately identify those adults with MCI who will develop dementia will enable future studies to occur that with examine the efficacy of pharmacological and non-pharmacological treatments in preventing or delaying the onset of dementia in those identified as suffering the high risk variants of MCI. This research group is planning to commence treatment trials in 2014.